FDA Inspection
G. Pohl-Boskamp GmbH & Co. KGG. Pohl-Boskamp GmbH & Co. KG – FDA Inspection, Sep 15, 2017
Record Details
This FDA Inspection record concerns G. Pohl-Boskamp GmbH & Co. KG, with an inspection on September 15, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 093da340-330a-497c-a406-9a0c0e0348ab
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1025477
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of G. Pohl-Boskamp GmbH & Co. KG
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 14, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 28, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 11, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 3, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 22, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for G. Pohl-Boskamp GmbH & Co. KG
- FDA Inspection 1264909 - 2023-09-14
- FDA Inspection 1156166 - 2020-08-28
- FDA Inspection 957110 - 2016-02-11
- FDA Inspection 935101 - 2015-07-03
- FDA Inspection 826846 - 2013-02-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.